Taro receives tentative approval for Lamotrigine tablets
Lamotrigine is a prescription product used for the treatment of seizures and is bioequivalent to GlaxoSmithKline’s Lamictal tablets. The tentative ANDA approval for Taro’s Lamotrigine tablets is an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.